Claus Bræstrup
Member of the board since 2008.
Re-elected in 2012 for a one-year term. Independent
Mr. Braestrup is former President and CEO of H. Lundbeck A/S.
Previously he has been Vice President of Pharmaceutical Research,
President of the CNS Division, and President of the Diabetes Care
Division, respectively, at Novo Nordisk A/S and Head of Preclinical
Drug Research with Schering AG.
Mr. Braestrup is Chairman of the Board of Probiodrug AG and
member of the boards of Santaris Pharma A/S and Evolva Holding
SA.
Mr. Braestrup has a degree of Doctorate of Medicine from the
University of Copenhagen, where he also for a period was Professor
in Neuroscience. He is writer and co-author of 125 scientific
publications.
Mr. Braestrup is a Danish national, born in 1945.
The special competences possessed by Mr. Braestrup that are
important for the performance of his duties are his scientific
qualifications and his extensive executive background within the
international pharmaceutical industry.
